SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, cilt.37, sa.5, ss.337-342, 2008 (SCI-Expanded)
Objectives: We aimed to investigate the relationship between anti-cyclic citrullinated peptide (anti-CCP) levels and bone mineral density (BMD), bone turnover, and radiographic damage in patients with rheumatoid arthritis (RA).